PIK3CA and esophageal squamous cell carcinoma: Aberrantly activated phosphatidylinositol 3‐kinase (PI3K) pathway via amplification or mutation of PIK3CA, hyperactivation of RTKs, alteration of AKT or functional loss of PTEN occurs frequently in ESCC.